Global Virtual Clinical Trials Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
- Category: Medical
- Published Date: Jan 2022
- Publisher: GRD Survey
- Pages: 102
Executive Summary
According to Intelligence Market Reports data, the global Virtual Clinical Trials market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.
This report studies the Virtual Clinical Trials market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Virtual Clinical Trials in these regions, from 2017 to 2028, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Interventional Trials
Observational Trials
Expanded Access Trials
Market Snapshot, By Application
Oncology
Cardiovascular Disease
Others
Main Market Players Analyzed in this report, including:
Science 37
PRA Health Sciences
Parexel
Oracle
Medidata
Medable
LEO Innovation Lab
IQVIA
ICON Plc
CRF Health
Covance
Clinical Ink
The study objectives of this report are:
To study and analyze the global Virtual Clinical Trials market size (Million USD) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2028.
To understand industry structure of Virtual Clinical Trials market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Virtual Clinical Trials manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Virtual Clinical Trials market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Virtual Clinical Trials submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Virtual Clinical Trials are as follows:
History Year: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Year 2023 to 2028
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
According to Intelligence Market Reports data, the global Virtual Clinical Trials market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.
This report studies the Virtual Clinical Trials market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Virtual Clinical Trials in these regions, from 2017 to 2028, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Interventional Trials
Observational Trials
Expanded Access Trials
Market Snapshot, By Application
Oncology
Cardiovascular Disease
Others
Main Market Players Analyzed in this report, including:
Science 37
PRA Health Sciences
Parexel
Oracle
Medidata
Medable
LEO Innovation Lab
IQVIA
ICON Plc
CRF Health
Covance
Clinical Ink
The study objectives of this report are:
To study and analyze the global Virtual Clinical Trials market size (Million USD) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2028.
To understand industry structure of Virtual Clinical Trials market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Virtual Clinical Trials manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Virtual Clinical Trials market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Virtual Clinical Trials submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Virtual Clinical Trials are as follows:
History Year: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Year 2023 to 2028
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Virtual Clinical Trials Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Virtual Clinical Trials Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Virtual Clinical Trials
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Oncology
3.2.2 Major Buyers in Cardiovascular Disease
4 Market Segment: by Type
4.1 Virtual Clinical Trials Type Introduction
4.1.1 Interventional Trials
4.1.2 Observational Trials
4.1.3 Expanded Access Trials
4.2 Global Virtual Clinical Trials Revenue by Type 2017-2022
5 Market Segment: by Application
5.1 Virtual Clinical Trials Type Introduction
5.1.1 Oncology
5.1.2 Cardiovascular Disease
5.1.3 Others
5.2 Global Virtual Clinical Trials Revenue by Application 2017-2022
6 Marke Segment: by Region
6.1 Global Virtual Clinical Trials Market by Region
6.2 North America Virtual Clinical Trials Market 2017-2022
6.3 Europe Virtual Clinical Trials Market 2017-2022
6.4 Asia Pacific Virtual Clinical Trials Market 2017-2022
6.5 South America Virtual Clinical Trials Market 2017-2022
6.6 Middle East and Africa Virtual Clinical Trials Market 2017-2022
7 North America
7.1 North America Virtual Clinical Trials Market by Country 2017-2022
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Virtual Clinical Trials Market by Country 2017-2022
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Virtual Clinical Trials Market by Country 2017-2022
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Virtual Clinical Trials Market by Country 2017-2022
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Virtual Clinical Trials Market by Country 2017-2022
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Science 37
12.1.1 Science 37 Company Information
12.1.2 Science 37 Virtual Clinical Trials Product Portfolio, Specification and Application
12.1.3 Science 37 Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.1.4 Science 37 Key Development
12.2 PRA Health Sciences
12.2.1 PRA Health Sciences Company Information
12.2.2 PRA Health Sciences Virtual Clinical Trials Product Portfolio, Specification and Application
12.2.3 PRA Health Sciences Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.2.4 PRA Health Sciences Key Development
12.3 Parexel
12.3.1 Parexel Company Information
12.3.2 Parexel Virtual Clinical Trials Product Portfolio, Specification and Application
12.3.3 Parexel Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.3.4 Parexel Key Development
12.4 Oracle
12.4.1 Oracle Company Information
12.4.2 Oracle Virtual Clinical Trials Product Portfolio, Specification and Application
12.4.3 Oracle Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.4.4 Oracle Key Development
12.5 Medidata
12.5.1 Medidata Company Information
12.5.2 Medidata Virtual Clinical Trials Product Portfolio, Specification and Application
12.5.3 Medidata Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.5.4 Medidata Key Development
12.6 Medable
12.6.1 Medable Company Information
12.6.2 Medable Virtual Clinical Trials Product Portfolio, Specification and Application
12.6.3 Medable Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.6.4 Medable Key Development
12.7 LEO Innovation Lab
12.7.1 LEO Innovation Lab Company Information
12.7.2 LEO Innovation Lab Virtual Clinical Trials Product Portfolio, Specification and Application
12.7.3 LEO Innovation Lab Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.7.4 Medable Key Development
12.9 ICON Plc
12.9.1 ICON Plc Company Information
12.9.2 ICON Plc Virtual Clinical Trials Product Portfolio, Specification and Application
12.9.3 ICON Plc Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.9.4 ICON Plc Key Development
12.8 IQVIA
12.8.1 IQVIA Company Information
12.8.2 IQVIA Virtual Clinical Trials Product Portfolio, Specification and Application
12.8.3 IQVIA Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.8.4 IQVIA Key Development
12.11 Covance
12.11.1 Covance Company Information
12.11.2 Covance Virtual Clinical Trials Product Portfolio, Specification and Application
12.11.3 Covance Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.11.4 Covance Key Development
12.12 Clinical Ink
12.12.1 Clinical Ink Company Information
12.12.2 Clinical Ink Virtual Clinical Trials Product Portfolio, Specification and Application
12.12.3 Clinical Ink Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.12.4 Clinical Ink Key Development
13 Global Virtual Clinical Trials Market Forecast by Region by Type and by Application
13.1 Global Virtual Clinical Trials Revenue Forecast 2023-2028
13.2 Global Virtual Clinical Trials Forecast by Regions
13.3 Global Virtual Clinical Trials Forecast by Type
13.4 Global Virtual Clinical Trials Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Virtual Clinical Trials Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Virtual Clinical Trials Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Virtual Clinical Trials
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Oncology
3.2.2 Major Buyers in Cardiovascular Disease
4 Market Segment: by Type
4.1 Virtual Clinical Trials Type Introduction
4.1.1 Interventional Trials
4.1.2 Observational Trials
4.1.3 Expanded Access Trials
4.2 Global Virtual Clinical Trials Revenue by Type 2017-2022
5 Market Segment: by Application
5.1 Virtual Clinical Trials Type Introduction
5.1.1 Oncology
5.1.2 Cardiovascular Disease
5.1.3 Others
5.2 Global Virtual Clinical Trials Revenue by Application 2017-2022
6 Marke Segment: by Region
6.1 Global Virtual Clinical Trials Market by Region
6.2 North America Virtual Clinical Trials Market 2017-2022
6.3 Europe Virtual Clinical Trials Market 2017-2022
6.4 Asia Pacific Virtual Clinical Trials Market 2017-2022
6.5 South America Virtual Clinical Trials Market 2017-2022
6.6 Middle East and Africa Virtual Clinical Trials Market 2017-2022
7 North America
7.1 North America Virtual Clinical Trials Market by Country 2017-2022
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Virtual Clinical Trials Market by Country 2017-2022
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Virtual Clinical Trials Market by Country 2017-2022
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Virtual Clinical Trials Market by Country 2017-2022
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Virtual Clinical Trials Market by Country 2017-2022
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Science 37
12.1.1 Science 37 Company Information
12.1.2 Science 37 Virtual Clinical Trials Product Portfolio, Specification and Application
12.1.3 Science 37 Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.1.4 Science 37 Key Development
12.2 PRA Health Sciences
12.2.1 PRA Health Sciences Company Information
12.2.2 PRA Health Sciences Virtual Clinical Trials Product Portfolio, Specification and Application
12.2.3 PRA Health Sciences Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.2.4 PRA Health Sciences Key Development
12.3 Parexel
12.3.1 Parexel Company Information
12.3.2 Parexel Virtual Clinical Trials Product Portfolio, Specification and Application
12.3.3 Parexel Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.3.4 Parexel Key Development
12.4 Oracle
12.4.1 Oracle Company Information
12.4.2 Oracle Virtual Clinical Trials Product Portfolio, Specification and Application
12.4.3 Oracle Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.4.4 Oracle Key Development
12.5 Medidata
12.5.1 Medidata Company Information
12.5.2 Medidata Virtual Clinical Trials Product Portfolio, Specification and Application
12.5.3 Medidata Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.5.4 Medidata Key Development
12.6 Medable
12.6.1 Medable Company Information
12.6.2 Medable Virtual Clinical Trials Product Portfolio, Specification and Application
12.6.3 Medable Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.6.4 Medable Key Development
12.7 LEO Innovation Lab
12.7.1 LEO Innovation Lab Company Information
12.7.2 LEO Innovation Lab Virtual Clinical Trials Product Portfolio, Specification and Application
12.7.3 LEO Innovation Lab Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.7.4 Medable Key Development
12.9 ICON Plc
12.9.1 ICON Plc Company Information
12.9.2 ICON Plc Virtual Clinical Trials Product Portfolio, Specification and Application
12.9.3 ICON Plc Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.9.4 ICON Plc Key Development
12.8 IQVIA
12.8.1 IQVIA Company Information
12.8.2 IQVIA Virtual Clinical Trials Product Portfolio, Specification and Application
12.8.3 IQVIA Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.8.4 IQVIA Key Development
12.11 Covance
12.11.1 Covance Company Information
12.11.2 Covance Virtual Clinical Trials Product Portfolio, Specification and Application
12.11.3 Covance Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.11.4 Covance Key Development
12.12 Clinical Ink
12.12.1 Clinical Ink Company Information
12.12.2 Clinical Ink Virtual Clinical Trials Product Portfolio, Specification and Application
12.12.3 Clinical Ink Virtual Clinical Trials Revenue and Gross Margin (2019-2021)
12.12.4 Clinical Ink Key Development
13 Global Virtual Clinical Trials Market Forecast by Region by Type and by Application
13.1 Global Virtual Clinical Trials Revenue Forecast 2023-2028
13.2 Global Virtual Clinical Trials Forecast by Regions
13.3 Global Virtual Clinical Trials Forecast by Type
13.4 Global Virtual Clinical Trials Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
no record found